SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-057690
Filing Date
2020-05-07
Accepted
2020-05-07 06:31:22
Documents
44
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2014563d1_10q.htm 10-Q 427412
2 EXHIBIT 31.1 tm2014563d1_ex31-1.htm EX-31.1 7753
3 EXHIBIT 31.2 tm2014563d1_ex31-2.htm EX-31.2 7814
4 EXHIBIT 32.1 tm2014563d1_ex32-1.htm EX-32.1 4386
5 EXHIBIT 32.2 tm2014563d1_ex32-2.htm EX-32.2 4385
  Complete submission text file 0001104659-20-057690.txt   2697047

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bcli-20200331.xml EX-101.INS 470591
7 XBRL TAXONOMY EXTENSION SCHEMA bcli-20200331.xsd EX-101.SCH 27534
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcli-20200331_cal.xml EX-101.CAL 27677
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcli-20200331_def.xml EX-101.DEF 85356
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcli-20200331_lab.xml EX-101.LAB 215899
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcli-20200331_pre.xml EX-101.PRE 177174
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36641 | Film No.: 20854441
SIC: 2836 Biological Products, (No Diagnostic Substances)